These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 29782732)

  • 1. Managing Pharmacy Trend Rates.
    Cassin N; Zeitel L; Patel H
    Benefits Q; 2017; 33(2):8-11. PubMed ID: 29782732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention Turns to Specialty Pharmacy.
    Dross D
    Benefits Q; 2017; 33(2):12-15. PubMed ID: 29782733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Employers Are Looking at Specialty Pharmacy Today.
    Morris D; Palermo A
    Benefits Q; 2017; 33(2):20-25. PubMed ID: 29782735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost containment interventions introduced on the community drugs schemes in Ireland-evaluation of expenditure trends using a national prescription claims database.
    Usher C; Tilson L; Bennett K; Barry M
    Clin Ther; 2012 Mar; 34(3):632-9. PubMed ID: 22381716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programs take the edge off pharmacy cost increases.
    Capitation Manag Rep; 2002 Apr; 9(4):53-6, 49. PubMed ID: 12004735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy team involvement in navigating the revenue cycle for high-cost medications in patients with cancer.
    Shank BR; Nguyen PAA; Pherson EC
    Am J Manag Care; 2017 Oct; 23(12 Spec No.):SP470-SP473. PubMed ID: 29087665
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
    Bazalo G; Weiss RC
    Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prescription Drug Cost-Containment Debate: The Outcome Affects Us.
    Baldwin P
    Consult Pharm; 2018 Nov; 33(11):668. PubMed ID: 30458909
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in systemic psoriasis treatment costs.
    Beyer V; Wolverton SE
    Arch Dermatol; 2010 Jan; 146(1):46-54. PubMed ID: 20083692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with a student-run patient medication assistance service.
    Murfin M; Wargo R; Vazquez A
    Am J Health Syst Pharm; 2013 Dec; 70(24):2176-9. PubMed ID: 24296839
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Narrow Pharmacy Networks and Medication Adherence.
    Polinski JM; Matlin OS; Sullivan C; Gagnon M; Brennan TA; Shrank WH
    JAMA Intern Med; 2015 Nov; 175(11):1850-3. PubMed ID: 26348504
    [No Abstract]   [Full Text] [Related]  

  • 15. The true cost and benefit of medication reduction.
    Aurigemma R
    Del Med J; 2009 Apr; 81(4):163-4. PubMed ID: 19552220
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
    Rosenberg ME; Rosenberg SP
    JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategic Planning for Health Care Cost Controls in a Constantly Changing Environment.
    Hembree WE
    Benefits Q; 2015; 31(4):38-45. PubMed ID: 26666091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ongoing threat of rising drug prices: ASHP's work goes on.
    Abramowitz PW
    Am J Health Syst Pharm; 2017 Apr; 74(8):551-552. PubMed ID: 28336677
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.